FGF19 and colitis: Furthermore, to investigate the effects of FGF19-M52, a novel protein-engineered mutant, on colitis, scientists injected AAV-FGF19-M52 or control AAV-GFP into WT and FXR-null mice, respectively, and induced colitis using DSS.